Ashley Rogier
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,104 | 115 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $368.77 | 25 | $0 (2024) |
| ABBVIE INC. | $243.74 | 13 | $0 (2024) |
| PFIZER INC. | $227.54 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $218.09 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $103.46 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $93.95 | 4 | $0 (2024) |
| Lilly USA, LLC | $90.89 | 6 | $0 (2024) |
| Exact Sciences Corporation | $90.33 | 5 | $0 (2024) |
| Amarin Pharma Inc. | $86.98 | 5 | $0 (2021) |
| Astellas Pharma US Inc | $71.64 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $695.71 | 36 | Novo Nordisk Inc ($145.01) |
| 2023 | $706.24 | 35 | GlaxoSmithKline, LLC. ($184.84) |
| 2022 | $331.24 | 21 | Novo Nordisk Inc ($130.24) |
| 2021 | $370.87 | 23 | Amarin Pharma Inc. ($86.98) |
All Payment Transactions
115 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $22.48 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $26.85 | General |
| Category: Biological | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: VACCINES | ||||||
| 10/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Obesity | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Obesity | ||||||
| 08/21/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: NEUROSCIENCE | ||||||
| 08/14/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: Diabetes | ||||||
| 08/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: NEUROSCIENCE | ||||||
| 07/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Diabetes | ||||||
| 07/24/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: VACCINES | ||||||
| 07/17/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.19 | General |
| Category: PSYCHIATRY | ||||||
| 07/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: Biological | ||||||
| 06/12/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Bone Health | ||||||
| 06/05/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: PSYCHIATRY | ||||||
| 05/30/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $22.07 | General |
| Category: Diabetes Care | ||||||
| 05/23/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Diabetes | ||||||
| 05/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 57 | 83 | $12,416 | $5,368 |
| 2022 | 2 | 49 | 72 | $9,774 | $3,747 |
| 2021 | 2 | 63 | 85 | $10,564 | $4,908 |
| 2020 | 2 | 38 | 47 | $5,738 | $2,228 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 28 | 51 | $7,548 | $3,221 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 12 | 12 | $2,748 | $1,279 | 46.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 20 | $2,120 | $867.83 | 40.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 34 | 51 | $7,548 | $2,891 | 38.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 21 | $2,226 | $856.44 | 38.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 37 | $5,476 | $2,714 | 49.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 48 | $5,088 | $2,195 | 43.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 18 | $2,664 | $1,175 | 44.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 25 | 29 | $3,074 | $1,053 | 34.2% |
About Ashley Rogier
Ashley Rogier is a Student in an Organized Health Care Education/Training Program healthcare provider based in Maumee, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/26/2019. The National Provider Identifier (NPI) number assigned to this provider is 1568013845.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ashley Rogier has received a total of $2,104 in payments from pharmaceutical and medical device companies, with $695.71 received in 2024. These payments were reported across 115 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,104).
As a Medicare-enrolled provider, Rogier has provided services to 207 Medicare beneficiaries, totaling 287 services with total Medicare billing of $16,251. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family
- Location Maumee, OH
- Active Since 09/26/2019
- Last Updated 11/03/2023
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1568013845
Products in Payments
- VRAYLAR (Drug) $224.12
- SHINGRIX (Biological) $187.07
- Rybelsus (Drug) $156.81
- REXULTI (Drug) $131.52
- PREVNAR 20 (Biological) $113.30
- Ozempic (Drug) $102.83
- FARXIGA (Drug) $91.23
- Cologuard Collection Kit (Device) $90.33
- Vascepa (Drug) $86.98
- NURTEC ODT (Drug) $74.59
- ELIQUIS (Drug) $71.41
- XARELTO (Drug) $65.06
- Wegovy (Drug) $63.79
- Veozah (Drug) $55.17
- TROKENDI XR (Drug) $55.16
- FREESTYLE LIBRE 3 (Device) $54.24
- Saxenda (Drug) $45.34
- MOUNJARO (Drug) $33.00
- EVENITY (Biological) $32.11
- JARDIANCE (Drug) $32.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Maumee
Dr. Ryan Kish, D.p.m, D.P.M
Student in an Organized Health Care Education/Training Program — Payments: $19,428
Dr. Ryan Griffith, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,159
Zachary Stephan
Student in an Organized Health Care Education/Training Program — Payments: $2,438
Dr. Thomas Bolig
Student in an Organized Health Care Education/Training Program — Payments: $29.16
Vidya Nelacanti, M.d, M.D
Student in an Organized Health Care Education/Training Program
Caleb Hallauer, Ph.d, PH.D
Student in an Organized Health Care Education/Training Program